These results were consistent with previous studies that LAPTM4B could be a diagnostic, prognostic and therapeutic factor in hepatocellular carcinoma, breast cancer, hepatocellular carcinoma, bladder cancer and renal cell carcinoma and so on (17, 18, 30–38). This evidence concerns the gene LAPTM4B and urinary bladder cancer.